Out At Home: FDA’s Vocal Support of Home Testing but Reluctance to Clear Novel OTC Home Tests
FDA Law Blog
JUNE 22, 2023
FDA hailed its authorization of the Lucira OTC home test for influenza and COVID-19 as “underscor[ing] the Agency’s continued commitment to increase availability of accurate and reliable at-home diagnostic tests” ( April 2023 FDA Update to CDC ). HbA1c, diagnosis of a particular virus, etc.). dried blood, in viral transport media).
Let's personalize your content